ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.36
+0.04 (+1.72%)
As of Aug 8, 2:00 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +907.6% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.36
Current
$2.36
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
829.2%
Low target
Base Case
$23.78
+907.6%
Avg target
Bull Case
$37.21
+1,476.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.00
-41.0% from high
52-Week Low
$2.03
+16.3% from low
Target vs 52W High
$23.78
+494.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%